ALASTAIR THOMPSON to Disease-Free Survival
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Disease-Free Survival.
Connection Strength
0.169
-
Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. Br J Cancer. 2014 Feb 04; 110(3):565-72.
Score: 0.048
-
Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer. Br J Cancer. 2012 Feb 28; 106(5):955-61.
Score: 0.043
-
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. Breast Cancer Res Treat. 2011 Jan; 125(1):279-87.
Score: 0.039
-
NT5E CpG island methylation is a favourable breast cancer biomarker. Br J Cancer. 2012 Jun 26; 107(1):75-83.
Score: 0.011
-
The impact of operative approach for oesophageal cancer on outcome: the transhiatal approach may influence circumferential margin involvement. Eur J Surg Oncol. 2012 Feb; 38(2):157-65.
Score: 0.011
-
Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen. J Clin Oncol. 2010 Oct 10; 28(29):e584-5; author reply e586.
Score: 0.010
-
A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Res. 2008; 10(5):R88.
Score: 0.008